Objective
To invest in businesses that are less than 7 years old and require funding to support the growth of the business and focusing on longer term returns to shareholders and ongoing tax free dividends.
Management group
Downing
Launch date
21/02/2017
Domicile
United Kingdom
Fund manager
Not Disclosed
Dividend frequency
Annually
Wind-up provisions
The Company has unlimited life.
Market Cap (m) Total assets (m) Price (last close) NAV Discount / premium (%) Gearing (%) Dividend yield (%) Dividend dates Ongoing charge (%)
11.19 13.16 47.50 55.85 -14.95 N/A 2.63 Aug 2.24 (31/03/2023)
Scroll

Note

Dividends

Dividends declared in last 12 months

Ex-Dividend date Payment date Dividend amount Special dividend Financial year
31/08/2023 29/09/2023 1.250 No 2023
Scroll

Performance (%)

Return type 1 year 3 years 5 years 10 years
Thames Ventures VCT 2 Healthcare shares Share price total return -28.2 -22.8 -45.5 N/A
VCT Specialist: Healthcare & Biotechnology AIC sector Share price total return N/A N/A N/A N/A
Scroll

Share structure

Number of shares
23,554,915

Traded volumes (number of shares)

  Yesterday 1 month 1 year 5 years
Total 0 0 199 619,921
Average N/A N/A 1 475
Scroll

Traded values (m)

  Yesterday 1 month 1 year 5 years
Total N/A N/A 0.00 0.46
Average N/A 0.00 0.00 0.00
Scroll

Trading details

ISIN TIDM Traded currency Stock exchange
GB00BDHF5D62 TV2H GBX London Stock Exchange - MAIN
Scroll

Top holdings

Data as at : 30/09/2023

Investment % of total assets
Arecor Therapeutics plc 18.4
Open Bionics Limited 11.4
FVRVS Limited (t/a Fundamental VR) 9.4
Cambridge Respiratory Innovations Limited 8.4
Invizius Limited 8.0
Closed Loop Medicine Limited 5.2
GENinCode plc 4.7
The Electrospinning Company Limited 4.4
Qkine Limited 3.0
MIP Discovery Limited 2.4

Morningstar logo Data provided by Morningstar.

FE fundinfo logo Company documents provided by FE fundinfo.